Effectiveness of Dry Needling and Ischemic Compression in Sternocleidomastoid, on Cervical Motor Control in Patients With Cervical Pain.

NCT ID: NCT03331653

Last Updated: 2018-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-11-10

Study Completion Date

2018-06-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will compare the effect of dry needling on the active trigger point on sternocleidomastoid versus the effect of dry needling at 1.5 centimeters of active trigger point on sternocleidomastoid, both combined with ischemic compression, on cervical pain and cervical motor control short and medium term.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cervical Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized Clinical Trial (RCT) with two groups.
Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Outcome Assessors
Double-blind, masking the patient and the outcomes assesor. A simple randomization will be performed with Epidat software.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Dry Needling and Ischemic Compression at the Trigger Point

Dry Needling and Ischemic Compression at the Trigger Point

Group Type EXPERIMENTAL

Dry Needling and Ischemic Compression at the Trigger Point

Intervention Type OTHER

The intervention consist on dry needling in the active trigger point, and next, do ischemic compression in the same point.

Intervention at 1.5 cm from the Trigger Point

Dry Needling and Ischemic Compression at 1.5 centimeters from the Trigger Point

Group Type ACTIVE_COMPARATOR

Dry Needling and Ischemic Compression at 1.5 centimeters from the Trigger Point

Intervention Type OTHER

The intervention consist on dry needling at 1.5 centimeters from the active trigger point, and next, do ischemic compression in the same point.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dry Needling and Ischemic Compression at the Trigger Point

The intervention consist on dry needling in the active trigger point, and next, do ischemic compression in the same point.

Intervention Type OTHER

Dry Needling and Ischemic Compression at 1.5 centimeters from the Trigger Point

The intervention consist on dry needling at 1.5 centimeters from the active trigger point, and next, do ischemic compression in the same point.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Be between 18 and 65 years old
* Have pain in the cervical region, which extends from the occipital to the 7th cervical vertebra.
* Have an active trigger point on the sternocleidomastoid.

Exclusion Criteria

* Present history of trauma in the neck.
* Present cervical radiculopathy
* Present a vestibular pathology
* Previous surgery on the neck or shoulder area
* Having a primary headache diagnosis
* Have received dry needling in the neck in the previous 6 months
* Present cognitive deficit.
* Be pregnant
* Taking anticoagulants.
* Have phobia to the needles (belonephobia).
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Alcala

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Aida Martín Rodríguez

Degree Physiotherapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Aida M. Rodríguez, Physiotherapy

Role: PRINCIPAL_INVESTIGATOR

Investigator

Esther S. Olmo, Physiotherapy

Role: PRINCIPAL_INVESTIGATOR

Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Alcalá

Alcalá de Henares, Madrid, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CEIM/HU/2017/15

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.